Synapse
⌘+K
Sign In
Sign Up for Free
Synapse
Sign In
Sign Up for Free
Home
Communities
Explore
More
Language
English
English
APLA Health
h-index: 62
Total citations: 14,363
Total papers: 820
Homepage:
http://www.apla.org/
Recent papers from APLA Health
Fentanyl dabbing with cannabis retail equipment: an ethnographic and drug-checking study
2026
Evaluation of Anti-HIV-1 HSPC-Based Gene Therapy with Negative Selection Marker in Pigtail Macaques
Viruses · 2026
Paradoxical relationships of interleukin-6 and tumor necrosis factor-alpha with methamphetamine use and body mass index
Communications Medicine · 2026
Two-Year Outcomes of a 211 Care Coordination Trial
PEDIATRICS · 2026
Macroscale Simulation of Post-Critical Behavior in Flexible Metamaterials
Journal of Applied Mechanics · 2026
Kaposi Sarcoma Herpes Virus Reprograms Mesenchymal Cell Glycosylation to control platelet-derived growth factor receptor A signaling
2026
ID #854 Updated findings from a phase 1 study of savolitinib in recurrent, progressive, or refractory medulloblastoma (MB), high-grade glioma (HGG), diffuse intrinsic pontine glioma (DIPG), and central nervous system (CNS) tumors harboring MET aberrations: A Pediatric Brain Tumor Consortium Trial: PBTC-049
Neuro-Oncology Pediatrics · 2026
ID #651 A phase 1/2 and surgical Pediatric Brain Tumor Consortium (PBTC) study evaluating the casein kinase 2 (CK2) inhibitor CX-4945 (silmitasertib sodium) in children and adults with recurrent sonic hedgehog (SHH) medulloblastoma (MB): PBTC-053
Neuro-Oncology Pediatrics · 2026
Efficacy and safety of aselective laser device to create centred capsulotomies in white intumescent cataracts: international multicentre study (LC-WIC study)
Journal of Cataract & Refractive Surgery · 2026
Early antiretroviral therapy and long-term cancer risk in HIV: 9-year outcomes from the START randomized trial
BMC Cancer · 2026
Response in first-in-human chemotherapy-free combination immunotherapy targeting lymphopenia in recurrent glioblastoma multiform (GBM): Nogapendekin alfa inbakicept (NAI) and PD-L1 t-haNK plus bevacizumab (BEV).
Journal of Clinical Oncology · 2026
A rock physics model for geophysical inversion in critical zone studies
Geophysics · 2026
“We need to keep in mind that battle fatigue”: A commentary on moral injury among substance use treatment and community service providers
Journal of Substance Use and Addiction Treatment · 2026
2 Risk factors for suicide-related revisits at US Pediatric Emergency Departments
Journal of Clinical and Translational Science · 2026
Bilingual Literacy Curricula for Bilingual Deaf Students
The Reading Teacher · 2026
Prospective HIV RNA screening with long-acting cabotegravir pre-exposure prophylaxis in HPTN 083
Clinical Infectious Diseases · 2026
Abstract CT089: Irreversible electroporation (IRE) with intratumoral CD40 antibody increases T-cell reactivity to personalized neoantigens in locally advanced pancreatic cancer
Cancer Research · 2026
Abstract LB214: Evaluating a church-based navigation model to increase breast cancer screening uptake: Results from a cluster randomized trial
Cancer Research · 2026
Abstract 4374: A novel RNA-LNP immunotherapy platform to drive anti-tumor efficacy in solid tumors
Cancer Research · 2026
Abstract 5813: Mass dose effects of the immunotheranostic [89Zr]Zr-LNTH-2403 by PET/CT and dosimetry in non-human primates
Cancer Research · 2026